Mindful Walking Neural Correlates of Executive Function in SC Older Adults at Risk of Dementias
The Impact of Mindful Walking on Neural Correlates of Executive Function in SC Older Adults at Risk of Alzheimer's and Dementias
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Fase 2
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Halle Prine, MS
- Numero di telefono: 8039997392
- Email: HPRINE@email.sc.edu
Luoghi di studio
-
-
South Carolina
-
Columbia, South Carolina, Stati Uniti, 29201
- Reclutamento
- University of South Carolina
-
Contatto:
- Chih-Hsiang Yang
- Numero di telefono: 8037771025
- Email: cy11@mailbox.sc.edu
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Age 60 or older
- Sedentary (sit ≥9hrs per day) and not meeting the US physical activity guidelines
Have at least one of the following ADRD risk factors:
i. family history of ADRD (>= first-degree relative) ii. subjective experience of cognitive complaints iii. currently overweight or obese (BMI≥25)
- Adequate hearing, visual and cognitive ability to complete study tasks and assessments
- Able to walk without others' assistance
- Medically stable with or without medication (do not expect to have major health status changes or a surgery in the next 4 months)
Exclusion Criteria:
- Diagnosis of ADRD or other brain abnormalities (i.e., strokes, epilepsy, Parkinson's disease)
- Diagnosis of mental disorders (i.e., depression)
- Inability to complete surveys on mobile device or wear the activity monitor (i.e., due to arthritis, physical limitations, or other reasons)
- Plan to move or have surgery in next 4 months
- Currently participate in other study involving physical activity or cognitive training that may interfere with the study outcomes
- Unable to provide consent due to disabilities
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Mindful walking arm
Older adults will participate in 8 sessions of mindful walking over one month
|
Implementing mindfulness skills during the walking movement
|
|
Comparatore attivo: Walking-only arm
Older adults will participate in 8 sessions of walking over one month
|
Older adults will participate in 8 sessions of walking over one month without being trained on mindfulness skills.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Hemodynamic activation signal
Lasso di tempo: Assessed at baseline, 4 weeks, 8 weeks
|
Hemodynamic activation in the prefrontal and parietal regions as an indication of EF.
Neural activation will be measured using functional nearinfrared spectroscopy (fNIRS).
|
Assessed at baseline, 4 weeks, 8 weeks
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Neuropsychological function
Lasso di tempo: Assessed at baseline, 4 weeks, 8 weeks
|
Montreal Cognitive Assessment (MoCA) is sensitive to measure normal cognitive aging from those with mild cognitive decline.
MoCA scores range from 1-30 to detect cognitive impairment.
Higher scores indicate better cognitive function.
|
Assessed at baseline, 4 weeks, 8 weeks
|
|
Executive function
Lasso di tempo: Assessed at Baseline, 4 weeks, 8 weeks
|
NIH Toolbox Cognitive Battery will be used to measure fluid cognitive abilities
|
Assessed at Baseline, 4 weeks, 8 weeks
|
|
Trait Mindfulness Levels
Lasso di tempo: Assessed at Baseline, 4 weeks, 8 weeks
|
Using the validated five-facet mindfulness scale (FFMQ) to measure trait mindfulness.
FFMQ scores range from 39-195.
Higher scores indicate higher trait mindfulness levels.
|
Assessed at Baseline, 4 weeks, 8 weeks
|
|
State Mindfulness Levels
Lasso di tempo: Assessed at baseline, 4 weeks, 8 weeks
|
Using the validated state mindfulness scale (SMS) to measure state mindfulness.
SMS scores range from 21-105.
Higher scores indicate higher state mindfulness levels.
|
Assessed at baseline, 4 weeks, 8 weeks
|
Altre misure di risultato
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Overall (in)activity levels
Lasso di tempo: Assessed at Baseline, 8 weeks
|
Using the physical activity and sedentary behavior questionnaire (PASB-Q) to assess older adults' overall (in)activity levels.
The questionnaire asks participants about their typical weekly physical activity minutes and daily sitting hours.
|
Assessed at Baseline, 8 weeks
|
|
Overall everyday cognition
Lasso di tempo: Assessed at Baseline, 8 weeks
|
Using everyday cognition scale (ECog) to assess memory, planning, organization, and divided attention in daily contexts.
Each item ranges from 1-4 points.
The overall score is calculated as an average of all completed items, resulting in a score range of 1 to 4. The higher scores represent worse everyday cognition.
|
Assessed at Baseline, 8 weeks
|
|
Overall health status
Lasso di tempo: Assessed at Baseline, 8 weeks
|
Using SF-36 questionnaire to assess overall health status.
For all domain scales and component scores, the scoring range is 0 to 100, with higher scores representing a more favorable or higher level of health.
|
Assessed at Baseline, 8 weeks
|
|
Height
Lasso di tempo: Assessed at Baseline, 8 weeks
|
Applying the NIH PhenX Toolkit protocol.
Participants' standing height is measured from the top of the participant's head to their heels.
The measure will be conducted in duplicates and will be recorded to the nearest 0.1 cm.
This measure will be combined with the weight measure to measure participants' BMI in kg/ m^2.
|
Assessed at Baseline, 8 weeks
|
|
Weight
Lasso di tempo: Baseline, 8 weeks
|
Applying the NIH PhenX Toolkit protocol.
Participants' weight will be measured using a digital floor scale.
Their weight will be measured in duplicates and will be recorded to the nearest 0.1 kg.
This measure will be combined with the height measure to calculate participants' BMI in kg/ m^2.
|
Baseline, 8 weeks
|
|
Mobility
Lasso di tempo: Assessed at baseline, 8 weeks
|
Applying the NIH PhenX Toolkit 10-meter walk protocol to assess mobility.
The test outcome is typically expressed as gait speed in meters per second (m/s).
The lower values indicate a higher risk of adverse health events.
|
Assessed at baseline, 8 weeks
|
|
Demographics
Lasso di tempo: Assessed at baseline
|
Collected basic demographics via an online survey.
All items are assessed using multiple-choice or multiple-selection questions of different types of participants' demographic status.
The response options are thus categorical but not a scale.
|
Assessed at baseline
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Pubblicazioni e link utili
Pubblicazioni generali
- Yang CH, Maher JP, Conroy DE. Acceptability of mobile health interventions to reduce inactivity-related health risk in central Pennsylvania adults. Prev Med Rep. 2015 Aug 13;2:669-72. doi: 10.1016/j.pmedr.2015.08.009. eCollection 2015.
- Carpenter C, Yang CH, West D. A Comparison of Sedentary Behavior as Measured by the Fitbit and ActivPAL in College Students. Int J Environ Res Public Health. 2021 Apr 8;18(8):3914. doi: 10.3390/ijerph18083914.
- Yang CH, Huh J, Mason TB, Belcher BR, Kanning M, Dunton GF. Mother-child dyadic influences of affect on everyday movement behaviors: evidence from an ecological momentary assessment study. Int J Behav Nutr Phys Act. 2020 May 11;17(1):56. doi: 10.1186/s12966-020-00951-6.
- Lopez NV, Yang CH, Belcher BR, Margolin G, Dunton GF. Within-Subject Associations of Maternal Physical Activity Parenting Practices on Children's Objectively Measured Moderate-to-Vigorous Physical Activity. J Pediatr Psychol. 2019 Apr 1;44(3):300-310. doi: 10.1093/jpepsy/jsy100.
- Yang CH, Hakun JG, Roque N, Sliwinski MJ, Conroy DE. Mindful walking and cognition in older adults: A proof of concept study using in-lab and ambulatory cognitive measures. Prev Med Rep. 2021 Jul 14;23:101490. doi: 10.1016/j.pmedr.2021.101490. eCollection 2021 Sep.
- Yang CH, Conroy DE. Feasibility of an Outdoor Mindful Walking Program for Reducing Negative Affect in Older Adults. J Aging Phys Act. 2018 Nov 7:1-10. doi: 10.1123/japa.2017-0390. Online ahead of print.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- MODCR00000007
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .